PBS updates

Aptamil Gold+ Pepti-Junior (protein hydrolysate formula with medium chain triglycerides)

protein hydrolysate formula with medium chain triglycerides powder for oral liquid, 450 g · ORAL · PBS code 8259Q

STREAMLINED

What it costs

AU$21.5 PBS-determined price per 8 units

Most patients pay only the standard PBS co-payment, not the full price above — up to AU$25.00 per script (general) or AU$7.70 (concession/Safety Net) in 2026. The figure above is what the PBS pays the pharmacy; the Australian Government subsidises the rest. Always confirm the current amount with your pharmacist.

  • • First listed on the PBS: 2011-11-01.
  • • Repeats: 5.
  • • PBS program: GE.
Eligibility criteria for subsidised access

The following is the government's own wording from the PBS Schedule, shown unchanged.

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Cows' milk protein enteropathy and intolerance to soy protein


Initial treatment


Must be treated by a specialist allergist, clinical immunologist, specialist paediatrician or specialist paediatric gastroenterologist and hepatologist, or in consultation with a specialist allergist, clinical immunologist, specialist paediatrician or specialist paediatric gastroenterologist and hepatologist; AND

The condition must not be isolated infant colic or reflux; AND

Patient must have failed to respond to a strict soy-based cows' milk protein free diet; AND

Patient must be up to the age of 24 months.

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Cows' milk protein enteropathy and intolerance to soy protein


Continuing treatment


Must be treated by a specialist allergist, clinical immunologist, specialist paediatrician or specialist paediatric gastroenterologist and hepatologist, or in consultation with a specialist allergist, clinical immunologist, specialist paediatrician or specialist paediatric gastroenterologist and hepatologist; AND

The condition must not be isolated infant colic or reflux; AND

Patient must have demonstrated a clinical improvement with the protein hydrolysate formula with medium chain triglycerides; AND

Patient must be up to the age of 24 months.

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Cows' milk protein enteropathy and intolerance to soy protein


Must be treated by a specialist allergist, clinical immunologist, specialist paediatrician or specialist paediatric gastroenterologist and hepatologist; AND

The condition must not be isolated infant colic or reflux; AND

Patient must have failed to respond to a strict soy-based cows' milk protein free diet; AND

Patient must be older than 24 months of age.

The name of the specialist must be documented in the patient's medical records

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Proven combined immunoglobulin E (IgE) mediated allergy to cows' milk protein and soy protein


Initial treatment for up to 6 months


Must be treated by a specialist allergist, clinical immunologist or specialist paediatric gastroenterologist and hepatologist, or in consultation with a specialist allergist, clinical immunologist or specialist paediatric gastroenterologist and hepatologist; AND

Patient must be up to the age of 24 months.

The name of the specialist must be documented in the patient's medical records

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Proven combined immunoglobulin E (IgE) mediated allergy to cows' milk protein and soy protein


Continuing treatment


Must be treated by a specialist allergist, clinical immunologist or specialist paediatric gastroenterologist and hepatologist; AND

Patient must be up to the age of 24 months.

The name of the specialist must be documented in the patient's medical records

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Biliary atresia

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Chronic liver failure with fat malabsorption

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Chylous ascites

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Cystic fibrosis

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Enterokinase deficiency

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Proven fat malabsorption

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Severe diarrhoea of greater than 2 weeks duration


Patient must be aged less than 4 months.

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Severe intestinal malabsorption including short bowel syndrome

Sponsor: Nutricia Australia Pty Limited ABN 99 076 246 752

Not medical advice. Voxsanity republishes public PBS data in plain English. PBS listing status and criteria can change; always confirm current subsidised availability with your doctor or pharmacist.

Source: Pharmaceutical Benefits Scheme (PBS), © Commonwealth of Australia. Data used and redistributed under permission; not modified from its original wording where displayed verbatim.